CVM GFI #245 - Hazard Analysis and Risk-Based Preventive Controls for Food for Animals

July 8, 2022

Illustration of a magnifying glass enlarging a checklist.

July 2022

The purpose of this guidance is to help animal food facilities develop a food safety plan that complies with FDA’s Hazard Analysis and Risk-Based Preventive Controls requirements.

Specifically, this document provides guidance on:

  • the biological, chemical (including radiological), and physical agents that are known or reasonably foreseeable hazards in manufacturing, processing, packing, and holding of animal food
  • the components of a food safety plan and the importance of each component
  • how to conduct a hazard analysis and develop a food safety plan for the animal food that you produce
  • identifying preventive controls for biological, chemical, and physical hazards associated with animal food and how to apply those preventive controls
  • preventive control management components (i.e., monitoring, corrective actions and corrections, and verification (including validation))
  • the recordkeeping requirements associated with the food safety plan and implementation of the food safety plan.

Download the Final Guidance Document

Read the Federal Register Notice

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs.

TAGS:

October 5, 2016

FDA Redefines the Term “Healthy” in Food Labeling

On Wednesday, September 28th, the FDA issued a final guidance document regarding the inclusion of the term “healthy” on the labels of food products. The guidance, entitled “Use of the Term ‘Healthy’...

Many fruits, vegetables, hamburgers, french fries, and pizza on a picnic table.

June 27, 2022

How to Interpret FDA’s Final Guidance - “Assessing the Effects of Food on Drugs in INDs and NDAs - Clinical Pharmacology Considerations”

On June 23, 2022, The FDA issued the final version of its Guidance for Industry titled “Assessing the Effects of Food on Drugs in INDs and NDAs - Clinical Pharmacology Considerations”. The most...

Hand holding a sign saying 'guidance.'

August 22, 2022

FDA Issues Revised Draft Guidance on Charging for Investigational Drugs Under an Investigational New Drug Application

August 2022 Draft Guidance This guidance provides information for industry, researchers, physicians, institutional review boards (IRBs), and patients about the implementation of FDA’s regulations on...